TWINBEECH CAPITAL LP - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 319 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.

Quarter-by-quarter ownership
TWINBEECH CAPITAL LP ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,139,234
+106.2%
99,280
+166.0%
0.06%
+100.0%
Q2 2023$1,522,236
-74.4%
37,328
-76.6%
0.03%
-75.0%
Q1 2023$5,936,328
+3.5%
159,279
-3.1%
0.12%
+10.1%
Q4 2022$5,734,520
+6.2%
164,360
+70.4%
0.11%
-23.2%
Q3 2022$5,398,00096,4700.14%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders